Yousef Zakharia News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Dr Zakharia on Real-World Outcomes With First-Line Axitinib Plus Pembrolizumab in RCC

Yousef Zakharia, MD, discusses the real-world treatment outcomes of first-line axitinib plus pembrolizumab in patients with advanced renal cell carcinoma based on International Metastatic RCC Database Consortium risk score.

Yousef zakhariaUniversity of iowa hospitalsInternational metastaticUniversity of iowaDatabase consortiumIowa hospitalsInternational kidney cancer symposiumOnclive tvGenitourinary cancer

First-line axitinib plus pembrolizumab supported in treatment of renal cell carcinoma

First-line axitinib plus pembrolizumab supported in treatment of renal cell carcinoma
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Yousef zakhariaUniversity of iowa carver college medicineIowa carver college

Ultimovacs Announces Publication in Clinical Cancer Research of the UV1-103 Phase I Malignant Melanoma Trial Results

Ultimovacs Announces Publication in Clinical Cancer Research of the UV1-103 Phase I Malignant Melanoma Trial Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesYousef zakhariaClinical cancer researchDrug administrationAmerican associationInternational congressSociety for melanoma researchMelanoma researchClinical cancerChief medical officerProgression free survivalFast trackHuman leukocyte antigenAbuse regulationNorwegian securities trading

Durvalumab Plus Guadecitabine Induces Responses in Checkpoint Inhibitor–Naïve ccRCC

The combination of durvalumab and guadecitabine generated early signs of clinical activity and tolerability in patients with advanced clear cell renal cell carcinoma, particularly those with no prior exposure to checkpoint inhibitors.

Iowa cityUnited statesBristol myers squibb medarexCastle biosciencesRoche genentechYousef zakhariaCardinal healthInternational metastaticUniversity of iowa holden comprehensive cancer centerMyovant sciencesDatabase consortiumIowa holden comprehensive cancer centerClovis oncologyUniversity of iowa holden comprehensive cancer centerGenitourinary cancersGu cancer

Ultimovacs Announces Plenary Oral Presentation of Phase I Melanoma Trial Results at the 19th International Congress of the Society for Melanoma Research (SMR)

Ultimovacs Announces Plenary Oral Presentation of Phase I Melanoma Trial Results at the 19th International Congress of the Society for Melanoma Research (SMR)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomCity ofYousef zakhariaMary ann changInternational congressSociety for melanoma researchDrug administrationMelanoma researchMedical oncologistClinical associate professorDirector phasei programIowa hospitalCarlos de sousaClinical activityCombined telomerase vaccinationUnresectable melanoma